NCT06646835

Brief Summary

This study will be conducted to determine the effect of stress ball application on anxiety and fetal heart rate in risk pregnant women before cesarean section. Women with risk pregnancies randomly assigned to intervention (n=44) and control (n=44) groups in a faculty hospital in Turkey will be included in the study. Pregnant women in the intervention group will be instructed how to use the stress ball in the obstetrics ward before cesarean section. During the practice, pregnant women will be asked to demonstrate the movements of tightening and loosening the stress ball to ensure correct use. It will be emphasized to the pregnant women that they should squeeze the ball once after counting to three, inhale when they squeeze the ball, exhale when they loosen their grip and focus only on the ball. Pregnant women in the control group will not receive any intervention other than routine general care. Data will be collected face-to-face by the researcher based on the self-reports of the pregnant women before cesarean section.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
88

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 14, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 17, 2024

Completed
13 days until next milestone

Study Start

First participant enrolled

October 30, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2025

Completed
Last Updated

July 30, 2025

Status Verified

July 1, 2025

Enrollment Period

5 months

First QC Date

October 14, 2024

Last Update Submit

July 29, 2025

Conditions

Keywords

AnxietyRisky pregnantNurseStress BallFetal heart rate

Outcome Measures

Primary Outcomes (2)

  • State-Trait anxiety score for anxiety

    The anxiety scale developed by Spielberger et al. in 1970 was designed to measure state and trait anxiety levels of individuals. The Turkish version of this scale was evaluated by Öner and Le Compte in 1983 and its reliability and validity were determined. The scale examines anxiety in two different dimensions: State Anxiety measures the feelings of an individual under a certain moment and condition, while Trait Anxiety refers to the general anxiety level of the individual. Each statement in the scale is a 4-point Likert scale (1-none, 2-somewhat, 3-a lot, 4-completely). Two types of expressions are used in the Spielberger State-Trait Anxiety Scale. Direct expressions indicate negative emotions and inverted expressions indicate positive emotions. Items 1,2,5,8,10,11,15,16,19 and 20 in the Spielberg State Anxiety Scale (SSAS) and items 26,27,30,33,36 and 39 in the Spielberg Trait Anxiety Scale (SSAS) are inverted statements. During the evaluation, after the total weights of the direct

    Anxiety levels will be assessed 5 minutes before intervention and 5 minutes after the end of the intervention.

  • Fetal heart rate

    Fetal heart rate will be measured by fetal hand-held Doppler before and after the intervention.

    Fetal heart rate levels will be assessed 5 minutes before intervention and 5 minutes after the end of the intervention.

Secondary Outcomes (3)

  • Pulse rate (beats/minute)

    Pulse rate of pregnant women will be assessed 5 minutes before intervention and 5 minutes after the end of the intervention.

  • respiration rate (times/minute)

    Respiration rate of pregnant women will be assessed 5 minutes before intervention and 5 minutes after the end of the intervention.

  • systolic and diastolic blood pressure (mmHg)

    Systolic and diastolic blood pressure of pregnant women will be assessed 5 minutes before intervention and 5 minutes after the end of the intervention.

Study Arms (2)

Control Group

NO INTERVENTION

Pregnant women in the control group will not receive any intervention other than routine general care before cesarean section.

Intervention Group

EXPERIMENTAL

Pregnant women in the intervention group will be explained how to use the stress ball in the obstetric ward before cesarean section. During the practice, pregnant women will be asked to demonstrate the movements of squeezing and loosening the stress ball to ensure correct use. It will be emphasized to the pregnant women that they should squeeze the ball once after counting to three, inhale when they squeeze the ball, exhale when they loosen their grip and focus only on the ball. In the obstetrics ward, this practice will cover the period starting from the time when the patient is waiting in her room to be taken to the operating room for cesarean section, until she is taken from the preop room to the operating room. In this process, the researcher will monitor whether the stress ball is applied correctly or not. In addition, in order to minimize the risk of infection in the hospital environment, the stress balls used will be disinfected with disposable aseptic wipes before being given

Behavioral: Stress Ball Intervention

Interventions

The stress ball is a simple and effective tool for reducing anxiety and relaxation as a non-pharmacological method (Yanes et al., 2018). Due to the limited pharmacological options available for pregnant women to reduce anxiety during cesarean section, alternative, complementary or supportive non-pharmacological methods and low-risk approaches are needed (Baltacı \& Başer, 2020). It is thought that squeezing the stress ball may be advantageous in reducing anxiety.

Intervention Group

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsWoman
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Volunteering to participate in the research,
  • Be over 18 years of age,
  • Having a medically diagnosed risky condition during pregnancy (diabetes, hypertension, threat of preterm labor, pre-eclampsia, etc.),
  • Compliance with at least one of the criteria in the "Ministry of Health Risk Assessment Form for Pregnancy" in the evaluation of current pregnancy,
  • Planning a cesarean delivery,
  • Being in the last trimester of pregnancy (28 weeks and above)
  • Having a single live fetus,
  • To be able to read and write Turkish.

You may not qualify if:

  • A diagnosed psychiatric illness,
  • Visual, hearing, speech, physical or mental disability,
  • Any communication barriers,
  • Cardiovascular disease in the pregnant woman and fetus,
  • Fetal distress,
  • Fetal anomaly,
  • Any physical or medical condition that prevents the use of a stress ball,
  • Need for urgent intervention before caesarean section according to the physician.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ondokuz Mayıs University

Samsun, Atakum, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Nazlı BALTACI, Assoc. Prof.

    baltacinazli@gmail.com

    STUDY DIRECTOR
  • Elif Eyüpoğlu

    elifeyupogluu@gmail.com

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The research will be conducted as a two-group, parallel, randomized, controlled experimental study with a pretest-posttest design.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, phD

Study Record Dates

First Submitted

October 14, 2024

First Posted

October 17, 2024

Study Start

October 30, 2024

Primary Completion

March 30, 2025

Study Completion

June 15, 2025

Last Updated

July 30, 2025

Record last verified: 2025-07

Locations